Here are four things to know.
1. Salix develops products for hepatic encephalopathy, IBS with diarrhea, opioid-induced constipation and ulcerative colitis.
2. Salix comprised approximately 18 percent of Valeant’s $8.7 billion revenue for fiscal year 2017.
3. Valeant acquired Salix in 2015.
4. Salix is Valeant’s most successful business after its Bausch + Lomb segment.
More articles on gastroenterology:
GI leader to know: Dr. Terry Baldwin of Illinois Gastroenterology Institute
Drs. Michael Kaczanowski, Seth Gross & more: 3 GI physicians making headlines
Self-employed gastroenterologists earn $24k more than employed: 4 statistics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
